Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme Q10 in Post-Exposure Protection for East Palestine Residents
NCT06962657Phase 2Not yet recruiting
- Sponsor
- University of California, San Diego
- Start
- May 2026
- Primary completion
- Oct 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Coenzyme Q10 mucoadhesive tablets in Toxicant-induced chronic multisymptom illness (TICMI), sponsored by University of California, San Diego. Planned start May 2026; status: not yet recruiting.
02
Drugs
Coenzyme Q10 mucoadhesive tablets
03
Conditions
Toxicant-induced chronic multisymptom illness (TICMI)
Beyond the preview
Go deeper on NCT06962657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06962657.